Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
The independent source for health policy research, polling, and news.
541 - 560 of 967 Results
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
The insurer has been notifying members about the network changes as the Dec. 7 deadline for choosing coverage for next year quickly approaches.
Sens. Orrin Hatch and Richard Burr join with Rep. Fred Upton to renew a proposal to repeal the health law but preserve some tax credits for insurance and cuts to some Medicare providers.
From Medicaid funding to paying for over-the-counter drugs, the legislation offered by House Republicans offers a far different pathway to coverage than Obamacare.
As part of their effort to improve quality while cutting costs, federal officials announced Monday that they want programs such as accountable care organizations and bundled care to account for 50 percent of traditional Medicare spending by the end of 2018.
Though not a part of the health law’s open enrollment period, Medicare’s enrollment period runs during some of the same time period. Changes to Medicare advantage and the so-called Medicare prescription drug “doughnut hole” are taking center stage.
The report credits slower growth in spending for private health insurance, Medicare, hospitals, physicians and clinical services.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Federal officials handle most of the requests in 2014 from beneficiaries seeking a hearing before a judge and cut into the heavy backlog. But cases from hospitals, doctors and other providers are still on hold.
In a region where bears outnumber people, a small medical facility sets a modern example for rural hospitals on life support.
As Medicare considers paying for knee replacement procedures outside the hospital, doctors debate patient choice and the potential for post-operation complications.
The Commonwealth Fund finds cost barriers and limits on care for Medicare beneficiaries consistently places the U.S. low on the list of an 11-nation ranking of how older people fare in industrialized nations.
Advocates say many poor seniors who need dialysis and cancer treatments will have few transportation options.
Kaiser Health News consumer columnist gives readers some basic information to help them weigh their Medicare options.
A consumer reporter shares what she learned when getting ready to join the federal health plan for seniors.
Older adults who hope to spend the end of their lives at home need to take key steps to make that possible.
The landmark settlement was supposed to be a victory for Medicare beneficiaries with chronic conditions and disabilities who had been denied coverage for skilled care because they didn’t meet “the improvement standard” — meaning they were unlikely to improve. But when Glenda Jimmo was denied coverage this spring for that same reason, her lawyers filed a second lawsuit.
The methodology behind KHN's analysis of the third year of the Medicare penalty program.
Jeffrey Brenner, a 2013 MacArthur Fellow and executive director of the Camden Coalition of Healthcare Providers, is betting that coordinated care for "super utilizer" patients will reduce health costs.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
© 2026 KFF